<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 16.1: The Metabolic Knot: Lean PCOS and Insulin Resistance</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL theme for Metabolic/Hormone */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #14b8a6, #0d9488);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-highlight {
            font-weight: 700;
            color: #0d9488;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #334155;
            font-weight: 600;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #475569;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #065f46;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #ecfdf5;
            border-radius: 8px;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #cbd5e1;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #fafafa;
            border-radius: 12px;
            border: 1px solid #eee;
        }

        .references-box h3 {
            font-size: 18px;
            color: #333;
            margin-bottom: 20px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-box li {
            font-size: 14px;
            color: #666;
            margin-bottom: 12px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .copyright {
            color: #888;
            font-size: 13px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 16: Advanced Case Studies</p>
            <h1 class="lesson-title">The Metabolic Knot: Lean PCOS and Insulin Resistance</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#phenotype"><span class="section-num">1</span>The Lean PCOS Phenotype</a></li>
                <li><a href="#biomarkers"><span class="section-num">2</span>Advanced Biomarkers</a></li>
                <li><a href="#insulin"><span class="section-num">3</span>Hidden Insulin Resistance</a></li>
                <li><a href="#bloom"><span class="section-num">4</span>B.L.O.O.M. Method‚Ñ¢ Application</a></li>
                <li><a href="#nutraceuticals"><span class="section-num">5</span>Nutraceutical Precision</a></li>
                <li><a href="#case-study"><span class="section-num">6</span>Case Study: The Athlete</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between Lean and Classic PCOS phenotypes using advanced lab metrics.</li>
                <li>Analyze the pathophysiology of hyperinsulinemia in non-obese populations.</li>
                <li>Interpret LH:FSH ratios and HOMA-IR to identify subclinical metabolic dysfunction.</li>
                <li>Apply the B.L.O.O.M. Method‚Ñ¢ to resolve androgen excess without restrictive dieting.</li>
                <li>Master the therapeutic application of Myo-Inositol to D-Chiro-Inositol ratios.</li>
            </ul>
        </div>

        <h2 id="phenotype">1. The Lean PCOS Phenotype Paradox</h2>
        <p>In the clinical landscape of Polycystic Ovary Syndrome (PCOS), the "Classic" phenotype‚Äîcharacterized by obesity and overt metabolic syndrome‚Äîis well-documented. However, the <span class="highlight">Lean PCOS</span> phenotype presents a unique challenge for practitioners. These clients typically have a Body Mass Index (BMI) within the normal range (18.5‚Äì24.9 kg/m¬≤), yet they exhibit the same hormonal dysregulation, including ovulatory dysfunction and hyperandrogenism.</p>

        <p>A common failure in <span class="highlight">Baseline Assessments (B)</span> occurs when clinicians dismiss the possibility of insulin resistance simply because the client is lean. Statistics show that approximately <span class="stat-highlight">20-30% of PCOS cases</span> are diagnosed in non-obese women. Furthermore, research indicates that lean women with PCOS often have significantly higher levels of visceral fat and lower insulin sensitivity compared to BMI-matched controls.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">75%</div>
                    <div class="stat-label">Lean PCOS w/ IR</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3:1</div>
                    <div class="stat-label">LH:FSH Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2x</div>
                    <div class="stat-label">Androgen Sensitivity</div>
                </div>
            </div>
        </div>

        <h2 id="biomarkers">2. Advanced Lab Interpretation: Beyond the Standard</h2>
        <p>When working within the B.L.O.O.M. Method‚Ñ¢, the "Baseline" phase requires looking beyond the standard Rotterdam Criteria. In Lean PCOS, the <span class="highlight">LH:FSH ratio</span> is a critical diagnostic clue. While a 1:1 ratio is considered optimal, Lean PCOS clients frequently present with a ratio of 2:1 or even 3:1. This elevation in Luteinizing Hormone (LH) is driven by an increased GnRH pulse frequency, which stimulates the ovarian theca cells to overproduce androgens.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Optimal Range (Lean)</th>
                        <th>Lean PCOS Pattern</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>LH:FSH Ratio</td>
                        <td>1:1</td>
                        <td>>2:1</td>
                        <td>Drives theca cell androgen production</td>
                    </tr>
                    <tr>
                        <td>Fasting Insulin</td>
                        <td>&lt; 5.0 uIU/mL</td>
                        <td>7.0 - 12.0 uIU/mL</td>
                        <td>Indicates subclinical hyperinsulinemia</td>
                    </tr>
                    <tr>
                        <td>HOMA-IR</td>
                        <td>&lt; 1.5</td>
                        <td>> 2.0</td>
                        <td>Quantifies cellular insulin resistance</td>
                    </tr>
                    <tr>
                        <td>SHBG</td>
                        <td>70 - 100 nmol/L</td>
                        <td>&lt; 40 nmol/L</td>
                        <td>Increases free (active) testosterone</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="insulin">3. Hidden Insulin Resistance in Non-Obese Clients</h2>
        <p>The "Metabolic Knot" in Lean PCOS is often <span class="highlight">postprandial hyperinsulinemia</span>. Even if fasting glucose appears normal, these clients often produce excessive insulin in response to carbohydrates. This excess insulin acts synergistically with LH to stimulate the ovaries, while simultaneously suppressing the production of Sex Hormone-Binding Globulin (SHBG) in the liver. A 2021 study involving 450 lean women found that <span class="stat-highlight">62% had a HOMA-IR score indicative of insulin resistance</span>, despite having a BMI of 21.</p>

        <p>This is why the B.L.O.O.M. Method‚Ñ¢ emphasizes "Listening to Your Body" (L) through biofeedback markers like post-meal energy crashes, sugar cravings, and "skinny-fat" body composition, rather than relying solely on the scale.</p>

        <h2 id="bloom">4. Applying the B.L.O.O.M. Method‚Ñ¢ to Androgen Excess</h2>
        <p>To <span class="highlight">Overcome Symptoms (O)</span> of androgen excess (acne, hirsutism, hair thinning) in lean clients, we must avoid the trap of aggressive caloric restriction. Caloric deficits in lean PCOS can actually worsen the condition by triggering a stress response in the HPA-axis, further disrupting the GnRH pulse frequency.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 1: The Misdiagnosed Athlete</p>
                    <p style="color:white; font-size: 13px; margin:0;">Lean PCOS vs. Hypothalamic Amenorrhea</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 26</h4>
                        <p>BMI: 20.2 | Distance Runner | Secondary Amenorrhea</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Sarah presented with a 9-month absence of menstruation, cystic acne along the jawline, and persistent fatigue despite high fitness levels. She had been told by her GP she had "Hypothalamic Amenorrhea" due to overtraining.</p>
                <p><strong>The Intervention:</strong> Using the B.L.O.O.M. Method‚Ñ¢ Baseline Assessment, we found an LH:FSH ratio of 2.8:1 and a Fasting Insulin of 9.2 uIU/mL. This confirmed Lean PCOS, not HA. We implemented:</p>
                <ul>
                    <li>Transition from chronic cardio to resistance training to improve muscle insulin sensitivity.</li>
                    <li>Increased complex carbohydrate intake (Carb Cycling) to lower cortisol.</li>
                    <li>Spearmint tea (2 cups/day) to lower free testosterone.</li>
                </ul>
                <p><strong>Outcome:</strong> Cycle returned in 64 days. Acne cleared by 70% within 3 months. HOMA-IR dropped from 2.1 to 1.3.</p>
            </div>
        </div>

        <h2 id="nutraceuticals">5. Nutraceutical Precision: The Inositol Ratio</h2>
        <p>Inositol is perhaps the most researched supplement for PCOS, but the <span class="highlight">ratio</span> is paramount for lean phenotypes. The body naturally maintains a 40:1 ratio of Myo-Inositol (MI) to D-Chiro-Inositol (DCI). MI is responsible for FSH signaling and glucose uptake, while DCI is involved in insulin-mediated androgen synthesis.</p>

        <p>In Lean PCOS, there is often a deficiency in the "epimerase" enzyme that converts MI to DCI in the ovaries. However, over-supplementing with DCI can actually be detrimental to egg quality. A 2022 meta-analysis confirmed that the <span class="highlight">40:1 ratio</span> is the gold standard for restoring ovulation and improving the metabolic knot without compromising oocyte maturation.</p>

        <h2 id="case-study">6. Case Study: The 28-Year-Old Athlete with Cystic Acne</h2>
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üèãÔ∏è‚Äç‚ôÄÔ∏è</div>
                <div>
                    <p class="box-label">Case Study 2: Metabolic Inflexibility</p>
                    <p style="color:white; font-size: 13px; margin:0;">Androgen Excess in a High-Performer</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Maya, 28</h4>
                        <p>BMI: 21.5 | CrossFit Athlete | Persistent Cystic Acne</p>
                    </div>
                </div>
                <p><strong>The Problem:</strong> Maya followed a strict "Paleo" diet and trained 6 days a week. Despite her "clean" lifestyle, her cystic acne was worsening, and her cycles were 45-50 days long. Her Baseline labs showed high DHEA-S (450 ug/dL) and low Progesterone (3 ng/mL) in the mid-luteal phase.</p>
                <p><strong>The B.L.O.O.M. Strategy:</strong> We identified that her high-intensity training combined with low carbohydrate intake was driving adrenal androgen production (DHEA-S). We shifted her to the <span class="highlight">Maintain & Thrive (M)</span> phase early by:</p>
                <ul>
                    <li>Adding 150g of whole-food carbs on training days.</li>
                    <li>Supplementing with 4g of 40:1 Inositol daily.</li>
                    <li>Introducing Saw Palmetto (450mg) to inhibit 5-alpha reductase (converting testosterone to the more potent DHT).</li>
                </ul>
                <p><strong>Outcome:</strong> Acne significantly reduced in 8 weeks. Cycle length stabilized at 31 days with confirmed ovulation (BBT tracking).</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge on Lean PCOS management.</p>
            
            <div style="margin-bottom: 25px;">
                <p><strong>1. Why is BMI an unreliable metric for assessing PCOS risk in the "Baseline" phase?</strong></p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    BMI does not account for visceral fat distribution or "Metabolically Unhealthy Normal Weight" (MUNW). Lean PCOS clients can have significant insulin resistance and hyperinsulinemia despite a normal weight.
                </div>
            </div>

            <div>
                <p><strong>2. What is the physiological consequence of a high LH:FSH ratio in Lean PCOS?</strong></p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    High LH levels (often 2-3x higher than FSH) overstimulate the ovarian theca cells, leading to excessive production of androgens (testosterone and androstenedione), which inhibits follicle maturation and causes acne/hirsutism.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Lesson Takeaways</p>
            <ul>
                <li><strong>Phenotype Diversity:</strong> Lean PCOS affects up to 30% of PCOS patients and is often missed due to normal BMI.</li>
                <li><strong>Metabolic Reality:</strong> 75% of lean PCOS clients have some degree of insulin resistance; HOMA-IR is a mandatory baseline lab.</li>
                <li><strong>The LH Factor:</strong> An LH:FSH ratio > 2:1 is a hallmark sign of the Lean PCOS "Metabolic Knot."</li>
                <li><strong>Inositol Precision:</strong> Always use the 40:1 Myo-to-D-Chiro ratio to support both insulin sensitivity and egg quality.</li>
                <li><strong>Avoid Restriction:</strong> Aggressive dieting can trigger adrenal androgens in lean clients; focus on nutrient density and carb timing instead.</li>
            </ul>
        </div>

        <div class="references-box">
            <h3>References & Further Reading</h3>
            <ul>
                <li>Toosy, S. et al. (2018). "Lean Polycystic Ovary Syndrome (PCOS): An Evidence-based Review of Diagnosis and Management." <i>Clinical Endocrinology.</i></li>
                <li>Morgante, G. et al. (2022). "The Role of Inositol Supplementation in Women with PCOS: A Systematic Review." <i>Journal of Ovarian Research.</i></li>
                <li>Baldani, D.P. et al. (2021). "Insulin Resistance in Lean Women with Polycystic Ovary Syndrome." <i>Journal of Clinical Medicine.</i></li>
                <li>Cassar, S. et al. (2016). "Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Gold-Standard Clamp Studies." <i>Human Reproduction Update.</i></li>
                <li>Marshall, J.C. et al. (2020). "Neuroendocrine aspects of polycystic ovary syndrome." <i>Endocrine Reviews.</i></li>
                <li>Dapas, M. et al. (2020). "Distinct Subtypes of Polycystic Ovary Syndrome with Novel Genetic Associations: An Unsupervised Learning Analysis." <i>PLOS Medicine.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Hormone Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary B.L.O.O.M. Method‚Ñ¢ Framework.</p>
        </footer>
    </div>
</body>

</html>